-
1
-
-
0036731992
-
-
Wagner LM, Guichard SM, Burger RA, Morton CL, Straign CM, Ashmun RA, Harris LC, Houghton PJ, Potter PM, Danks MK. Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patients. Cancer Res 2002; 62: 5001-7.
-
(2002)
Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: Preclinical assessment and application to bone marrow samples from neuroblastoma patients. Cancer Res
, vol.62
, pp. 5001-5007
-
-
Wagner, L.M.1
Guichard, S.M.2
Burger, R.A.3
Morton, C.L.4
Straign, C.M.5
Ashmun, R.A.6
Harris, L.C.7
Houghton, P.J.8
Potter, P.M.9
Danks, M.K.10
-
2
-
-
0033554684
-
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group
-
Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999; 341: 1165-73.
-
(1999)
N Engl J Med
, vol.341
, pp. 1165-1173
-
-
Matthay, K.K.1
Villablanca, J.G.2
Seeger, R.C.3
Stram, D.O.4
Harris, R.E.5
Ramsay, N.K.6
Swift, P.7
Shimada, H.8
Black, C.T.9
Brodeur, G.M.10
Gerbing, R.B.11
Reynolds, C.P.12
-
3
-
-
0029758492
-
-
Stram DO, Matthay KK, O'Leary M, Reynolds CP, Haase GM, Atkinson JB, Brodeur GM, Seeger RC. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol 1996; 14: 2417-26.
-
(1996)
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: A report of two concurrent Children's Cancer Group studies. J Clin Oncol
, vol.14
, pp. 2417-2426
-
-
Stram, D.O.1
Matthay, K.K.2
O'Leary, M.3
Reynolds, C.P.4
Haase, G.M.5
Atkinson, J.B.6
Brodeur, G.M.7
Seeger, R.C.8
-
4
-
-
33745528137
-
-
George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, Pulsipher M, Grupp SA, Diller L. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J Clin Oncol 2006; 24: 2891-6.
-
(2006)
High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: Long-term survival update. J Clin Oncol
, vol.24
, pp. 2891-2896
-
-
George, R.E.1
Li, S.2
Medeiros-Nancarrow, C.3
Neuberg, D.4
Marcus, K.5
Shamberger, R.C.6
Pulsipher, M.7
Grupp, S.A.8
Diller, L.9
-
5
-
-
36148971752
-
-
Kim JY, Baek HJ, Han DK, Sung JS, Nam TK, Yoon MS, Kook H, Hwang TJ. Improved survival in neuroblastoma by autologous periph eral blood stem cell transplantation: a single institution experience. Clin Pediatr Hematol-Oncol 2006; 13: 9-21.
-
(2006)
Improved survival in neuroblastoma by autologous periph eral blood stem cell transplantation: A single institution experience. Clin Pediatr Hematol-Oncol
, vol.13
, pp. 9-21
-
-
Kim, J.Y.1
Baek, H.J.2
Han, D.K.3
Sung, J.S.4
Nam, T.K.5
Yoon, M.S.6
Kook, H.7
Hwang, T.J.8
-
6
-
-
36148974424
-
-
O'leary MC, Sather HN, Ramsay NK, Harris R, Strandjord S, Romansdy S, Hasse G, Shimada H, Novak L, Siegel S, Hann HW, Brodeur G, Seeger R. Intensive chemotherapy for poor prognosis neuroblastoma. Proc Am Assoc Cancer Res 1990; 31: 201.
-
(1990)
Intensive chemotherapy for poor prognosis neuroblastoma. Proc Am Assoc Cancer Res
, vol.31
, pp. 201
-
-
O'leary, M.C.1
Sather, H.N.2
Ramsay, N.K.3
Harris, R.4
Strandjord, S.5
Romansdy, S.6
Hasse, G.7
Shimada, H.8
Novak, L.9
Siegel, S.10
Hann, H.W.11
Brodeur, G.12
Seeger, R.13
-
7
-
-
0026083733
-
-
Pole JG, Casper J, Elfenbein G, Gee A, Gross S, Janssen W, Koch P, Marcus R, Pick T, Shuster J, Spruce W, Thomas P, Yeager A. Highdose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 1991; 9: 152-8.
-
(1991)
Highdose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol
, vol.9
, pp. 152-158
-
-
Pole, J.G.1
Casper, J.2
Elfenbein, G.3
Gee, A.4
Gross, S.5
Janssen, W.6
Koch, P.7
Marcus, R.8
Pick, T.9
Shuster, J.10
Spruce, W.11
Thomas, P.12
Yeager, A.13
-
8
-
-
10744224594
-
-
Ryu KH, Ahn HS, Koo HH, Kook H, Kim MK, Kim HK, Ghim T, Moon HN, Seo JJ, Sung KW, Shin HY, Yoo ES, Lyu CJ, Lee YH, Lee H, Cho B, Cho HS, Choi HS, Hah JO, Hwang TJ. Autologous stem cell transplantation for the treatment of neuroblastoma in Korea. J Korean Med Sci 2003; 18: 242-7.
-
(2003)
Autologous stem cell transplantation for the treatment of neuroblastoma in Korea. J Korean Med Sci
, vol.18
, pp. 242-247
-
-
Ryu, K.H.1
Ahn, H.S.2
Koo, H.H.3
Kook, H.4
Kim, M.K.5
Kim, H.K.6
Ghim, T.7
Moon, H.N.8
Seo, J.J.9
Sung, K.W.10
Shin, H.Y.11
Yoo, E.S.12
Lyu, C.J.13
Lee, Y.H.14
Lee, H.15
Cho, B.16
Cho, H.S.17
Choi, H.S.18
Hah, J.O.19
Hwang, T.J.20
more..
-
9
-
-
18344363232
-
-
Imaizumi M, Watanabe A, Kikuta A, Takano T, Ito E, Shimizu T, Tsuchiya S, Iinuma K, Konno T, Ohi R, Hayashi Y. Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation: a retrospective analysis from the Tohoku Neuroblastoma Study Group. Tohoku J Exp Med 2001; 195: 73-83.
-
(2001)
Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation: A retrospective analysis from the Tohoku Neuroblastoma Study Group. Tohoku J Exp Med
, vol.195
, pp. 73-83
-
-
Imaizumi, M.1
Watanabe, A.2
Kikuta, A.3
Takano, T.4
Ito, E.5
Shimizu, T.6
Tsuchiya, S.7
Iinuma, K.8
Konno, T.9
Ohi, R.10
Hayashi, Y.11
-
11
-
-
0028263529
-
-
Rill DR, Santana VM, Roberts WM, Nilson T, Bowman LC, Krance RA, Heslop HE, Moen RC, Ihle JN, Brenner MK. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994; 84: 380-3.
-
(1994)
Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood
, vol.84
, pp. 380-383
-
-
Rill, D.R.1
Santana, V.M.2
Roberts, W.M.3
Nilson, T.4
Bowman, L.C.5
Krance, R.A.6
Heslop, H.E.7
Moen, R.C.8
Ihle, J.N.9
Brenner, M.K.10
-
12
-
-
0028324568
-
-
Moss TJ, Cairo M, Santana VM, Weinthal J, Hurvitz C, Bostrom B. Clonogenicity of circulating neuroblastoma cells: implications regarding peripheral blood stem cell transplantation. Blood 1994; 83: 3085-9.
-
(1994)
Clonogenicity of circulating neuroblastoma cells: Implications regarding peripheral blood stem cell transplantation. Blood
, vol.83
, pp. 3085-3089
-
-
Moss, T.J.1
Cairo, M.2
Santana, V.M.3
Weinthal, J.4
Hurvitz, C.5
Bostrom, B.6
-
13
-
-
0027471156
-
-
Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-6.
-
(1993)
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet
, vol.341
, pp. 85-86
-
-
Brenner, M.K.1
Rill, D.R.2
Moen, R.C.3
Krance, R.A.4
Mirro Jr, J.5
Anderson, W.F.6
Ihle, J.N.7
-
14
-
-
0030854884
-
Positive selection and transplantation of peripheral CD34+ progenitor cells: Feasibility and purging efficacy in pediatric patients with neuroblastoma
-
Handgretinger R, Greil J, Schurmann U, Lang P, Gonzalez-Ramella O, Schmidt I, Fuhrer R, Niethammer D, Klingebiel T. Positive selection and transplantation of peripheral CD34+ progenitor cells: feasibility and purging efficacy in pediatric patients with neuroblastoma. J Hematother 1997; 6: 235-42.
-
(1997)
J Hematother
, vol.6
, pp. 235-242
-
-
Handgretinger, R.1
Greil, J.2
Schurmann, U.3
Lang, P.4
Gonzalez-Ramella, O.5
Schmidt, I.6
Fuhrer, R.7
Niethammer, D.8
Klingebiel, T.9
-
15
-
-
0031431540
-
Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry
-
Lode HN, Handgretinger R, Schuermann U, Seitz G, Klingebiel T, Niethammer D, Beck J. Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry. Eur J Cancer 1997; 33: 2024-30.
-
(1997)
Eur J Cancer
, vol.33
, pp. 2024-2030
-
-
Lode, H.N.1
Handgretinger, R.2
Schuermann, U.3
Seitz, G.4
Klingebiel, T.5
Niethammer, D.6
Beck, J.7
-
16
-
-
0033660416
-
CD34 selection as a stem cell purging strategy for neuroblastoma: Preclinical and clinical studies
-
Donovan J, Temel J, Zuckerman A, Gribben J, Fang J, Pierson G, Ross A, Diller L, Grupp SA. CD34 selection as a stem cell purging strategy for neuroblastoma: preclinical and clinical studies. Med Pediatr Oncol 2000; 35: 677-82.
-
(2000)
Med Pediatr Oncol
, vol.35
, pp. 677-682
-
-
Donovan, J.1
Temel, J.2
Zuckerman, A.3
Gribben, J.4
Fang, J.5
Pierson, G.6
Ross, A.7
Diller, L.8
Grupp, S.A.9
-
17
-
-
10744221466
-
Ex vivo expansion of autologous PB CD34+ cells provides a purging effect in children with neuroblastoma
-
Kanold J, Halle P, Tchirkov A, Berger M, Giarratana MC, Kobari L, Boiret N, Paillard C, Demeocq F, Douay L. Ex vivo expansion of autologous PB CD34+ cells provides a purging effect in children with neuroblastoma. Bone Marrow Transplant 2003; 32: 485-8.
-
(2003)
Bone Marrow Transplant
, vol.32
, pp. 485-488
-
-
Kanold, J.1
Halle, P.2
Tchirkov, A.3
Berger, M.4
Giarratana, M.C.5
Kobari, L.6
Boiret, N.7
Paillard, C.8
Demeocq, F.9
Douay, L.10
-
19
-
-
0344654819
-
Neuroblastoma cells can express the hematopoietic progenitor cell antigen CD34 as detected at surface protein and mRNA level
-
Hafer R, Voigt A, Gruhn B, Zintl F. Neuroblastoma cells can express the hematopoietic progenitor cell antigen CD34 as detected at surface protein and mRNA level. J Neuroimmunol 1999; 96: 201-6.
-
(1999)
J Neuroimmunol
, vol.96
, pp. 201-206
-
-
Hafer, R.1
Voigt, A.2
Gruhn, B.3
Zintl, F.4
-
20
-
-
0033917099
-
-
Grupp SA, Stern JW, Bunin N, Nancarrow C, Ross AA, Mogul M, Adams R, Grier HE, Gorlin JB, Shamberger R, Marcus K, Neuberg D, Weinstein HJ, Diller L. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol 2000; 18: 2567-75.
-
(2000)
Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol
, vol.18
, pp. 2567-2575
-
-
Grupp, S.A.1
Stern, J.W.2
Bunin, N.3
Nancarrow, C.4
Ross, A.A.5
Mogul, M.6
Adams, R.7
Grier, H.E.8
Gorlin, J.B.9
Shamberger, R.10
Marcus, K.11
Neuberg, D.12
Weinstein, H.J.13
Diller, L.14
-
21
-
-
10344252250
-
-
Ayash LJ, Elias A, Schwartz G, Wheeler C, Ibrahim J, Teicher BA, Reich E, Warren D, Lynch C, Richardson P, Schnipper L, Frei E 3rd, Antman K. Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin. J Clin Oncol 1996; 14: 2984-92.
-
(1996)
Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: No improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin. J Clin Oncol
, vol.14
, pp. 2984-2992
-
-
Ayash, L.J.1
Elias, A.2
Schwartz, G.3
Wheeler, C.4
Ibrahim, J.5
Teicher, B.A.6
Reich, E.7
Warren, D.8
Lynch, C.9
Richardson, P.10
Schnipper, L.11
Frei 3rd, E.12
Antman, K.13
-
22
-
-
0032881730
-
-
Fitoussi O, Simon D, Brice P, Makke J, Scrobohaci ML, Bibi Triki T, Hennequin C, Ferme C, Gisselbrecht C. Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma. Bone Marrow Transplant 1999; 24: 747-55.
-
(1999)
Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma. Bone Marrow Transplant
, vol.24
, pp. 747-755
-
-
Fitoussi, O.1
Simon, D.2
Brice, P.3
Makke, J.4
Scrobohaci, M.L.5
Bibi Triki, T.6
Hennequin, C.7
Ferme, C.8
Gisselbrecht, C.9
-
23
-
-
0031001279
-
-
Barlogie B, Jagannath S, Vesole DH, Naucke S, Cheson B, Mattox S, Bracy D, Salmon S, Jacobson J, Crowley J, Tricot G. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 1997; 89: 789-93.
-
(1997)
Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood
, vol.89
, pp. 789-793
-
-
Barlogie, B.1
Jagannath, S.2
Vesole, D.H.3
Naucke, S.4
Cheson, B.5
Mattox, S.6
Bracy, D.7
Salmon, S.8
Jacobson, J.9
Crowley, J.10
Tricot, G.11
-
24
-
-
0027393196
-
Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: The LMCE2 study
-
Philip T, Ladenstein R, Zucker JM, Pinkerton R, Bouffet E, Louis D, Siegert W, Bernard JL, Frappaz D, Coze C, Wyss M, Beck D, Soulliet G, Michon J, Philip I, Chauvin F, Favrot M, Biron P. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study. Br J Cancer 1993; 67: 119-27.
-
(1993)
Br J Cancer
, vol.67
, pp. 119-127
-
-
Philip, T.1
Ladenstein, R.2
Zucker, J.M.3
Pinkerton, R.4
Bouffet, E.5
Louis, D.6
Siegert, W.7
Bernard, J.L.8
Frappaz, D.9
Coze, C.10
Wyss, M.11
Beck, D.12
Soulliet, G.13
Michon, J.14
Philip, I.15
Chauvin, F.16
Favrot, M.17
Biron, P.18
-
25
-
-
0037368013
-
-
Sung KW, Yoo KH, Chung EH, Jung HL, Koo HH, Shin HJ, Lee SK, Lim DH, Kim DW, Park HK, Cho EJ, Kim SW. Successive double high-dose chemotherapy with peripheral blood stem cell rescue collected during a single leukapheresis round in patients with highrisk pediatric solid tumors: a pilot study in a single center. Bone Marrow Transplant 2003; 31: 447-52.
-
(2003)
Successive double high-dose chemotherapy with peripheral blood stem cell rescue collected during a single leukapheresis round in patients with highrisk pediatric solid tumors: A pilot study in a single center. Bone Marrow Transplant
, vol.31
, pp. 447-452
-
-
Sung, K.W.1
Yoo, K.H.2
Chung, E.H.3
Jung, H.L.4
Koo, H.H.5
Shin, H.J.6
Lee, S.K.7
Lim, D.H.8
Kim, D.W.9
Park, H.K.10
Cho, E.J.11
Kim, S.W.12
-
26
-
-
0036569839
-
-
Kletzel M, Katzenstein HM, Haut PR, Yu AL, Morgan E, Reynolds M, Geissler G, Marymount MH, Liu D, Kalapurakal JA, Shore RM, Bardo DM, Schmoldt J, Rademaker AW, Cohn SL. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study. J Clin Oncol 2002; 20: 2284-92.
-
(2002)
Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: Results of the Chicago Pilot II Study. J Clin Oncol
, vol.20
, pp. 2284-2292
-
-
Kletzel, M.1
Katzenstein, H.M.2
Haut, P.R.3
Yu, A.L.4
Morgan, E.5
Reynolds, M.6
Geissler, G.7
Marymount, M.H.8
Liu, D.9
Kalapurakal, J.A.10
Shore, R.M.11
Bardo, D.M.12
Schmoldt, J.13
Rademaker, A.W.14
Cohn, S.L.15
-
30
-
-
0028901770
-
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation
-
Villablanca JG, Khan AA, Avramis VI, Seeger RC, Matthay KK, Ramsay NK, Reynolds CP. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol 1995; 13: 894-901.
-
(1995)
J Clin Oncol
, vol.13
, pp. 894-901
-
-
Villablanca, J.G.1
Khan, A.A.2
Avramis, V.I.3
Seeger, R.C.4
Matthay, K.K.5
Ramsay, N.K.6
Reynolds, C.P.7
-
31
-
-
0024231234
-
Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients
-
Mier JW, Vachino G, van der Meer JW, Numerof RP, Adams S, Cannon JG, Bernheim HA, Atkins MB, Parkinson DR, Dinarello CA. Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J Clin Immunol 1988; 8: 426-36.
-
(1988)
J Clin Immunol
, vol.8
, pp. 426-436
-
-
Mier, J.W.1
Vachino, G.2
van der Meer, J.W.3
Numerof, R.P.4
Adams, S.5
Cannon, J.G.6
Bernheim, H.A.7
Atkins, M.B.8
Parkinson, D.R.9
Dinarello, C.A.10
-
32
-
-
0027980190
-
Interleukin-2: Solid-tumor therapy
-
Oppenheim MH, Lotze MT. Interleukin-2: solid-tumor therapy. Oncology 1994; 51: 154-69.
-
(1994)
Oncology
, vol.51
, pp. 154-169
-
-
Oppenheim, M.H.1
Lotze, M.T.2
-
33
-
-
10344265995
-
High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: Pilot study
-
Pardo N, Marti F, Fraga G, Illa J, Badell I, Peiro M, Bertran E, Garcia J, Rueda F, Cubells J. High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: pilot study. Med Pediatr Oncol 1996; 27: 534-9.
-
(1996)
Med Pediatr Oncol
, vol.27
, pp. 534-539
-
-
Pardo, N.1
Marti, F.2
Fraga, G.3
Illa, J.4
Badell, I.5
Peiro, M.6
Bertran, E.7
Garcia, J.8
Rueda, F.9
Cubells, J.10
-
34
-
-
0034668028
-
Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma
-
Toren A, Nagler A, Rozenfeld-Granot G, Levanon M, Davidson J, Bielorai B, Kaplinsky C, Meitar D, Mandel M, Ackerstein A, Ballin A, Attias D, Biniaminov M, Rosenthal E, Brok-Simoni F, Rechavi G, Kaufmann Y. Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma. Transplantation 2000; 70: 1100-4.
-
(2000)
Transplantation
, vol.70
, pp. 1100-1104
-
-
Toren, A.1
Nagler, A.2
Rozenfeld-Granot, G.3
Levanon, M.4
Davidson, J.5
Bielorai, B.6
Kaplinsky, C.7
Meitar, D.8
Mandel, M.9
Ackerstein, A.10
Ballin, A.11
Attias, D.12
Biniaminov, M.13
Rosenthal, E.14
Brok-Simoni, F.15
Rechavi, G.16
Kaufmann, Y.17
-
35
-
-
36148951096
-
Effects of low dose interleukin-2 therapy after high dose chemotherapy and autologous PBSCT in childhood AML and stage 4 neuroblastoma
-
Kim MK, Lyu CJ, Park SH, Cho HS, Yang CH, Kim HM, Kang SH, Kim KY. Effects of low dose interleukin-2 therapy after high dose chemotherapy and autologous PBSCT in childhood AML and stage 4 neuroblastoma. Korean J Pediatr Hematol-Oncol 2000; 7: 82-91.
-
(2000)
Korean J Pediatr Hematol-Oncol
, vol.7
, pp. 82-91
-
-
Kim, M.K.1
Lyu, C.J.2
Park, S.H.3
Cho, H.S.4
Yang, C.H.5
Kim, H.M.6
Kang, S.H.7
Kim, K.Y.8
-
36
-
-
0029039308
-
A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Childrens Cancer Group study
-
Bauer M, Reaman GH, Hank JA, Cairo MS, Anderson P, Blazar BR, Frierdich S, Sondel PM. A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Childrens Cancer Group study. Cancer 1995; 75: 2959-65.
-
(1995)
Cancer
, vol.75
, pp. 2959-2965
-
-
Bauer, M.1
Reaman, G.H.2
Hank, J.A.3
Cairo, M.S.4
Anderson, P.5
Blazar, B.R.6
Frierdich, S.7
Sondel, P.M.8
-
37
-
-
0343851075
-
Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients
-
Vlk V, Eckschlager T, Kavan P, Kabickova E, Koutecky J, Sobota V, Bubenik J, Pospisilova D. Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients. Pediatr Hematol Oncol 2000; 17: 31-44.
-
(2000)
Pediatr Hematol Oncol
, vol.17
, pp. 31-44
-
-
Vlk, V.1
Eckschlager, T.2
Kavan, P.3
Kabickova, E.4
Koutecky, J.5
Sobota, V.6
Bubenik, J.7
Pospisilova, D.8
|